GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Valuation Rank

Simris Alg AB (OSTO:SIMRIS B) Valuation Rank


View and export this data going back to 2016. Start your Free Trial

What is Simris Alg AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Simris Alg AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Simris Alg AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Simris Alg AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Simris Alg AB (OSTO:SIMRIS B) » Definitions » Valuation Rank
Comparable Companies
OSTO:SPRINT OSTO:CMOTEC B XSAT:DBP B OSTO:COMBI XSAT:PHAL OSTO:2CUREX XSAT:RESP OSTO:MODTX XSAT:CHOSA XSAT:NIDHOG VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Website
https://www.simrisalg.se
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.